Behavioral Science Banner Maps The Future Of GSK Consumer Business
This article was originally published in The Tan Sheet
Executive Summary
Roger Scarlett-Smith, the new head of GlaxoSmithKline's North American Consumer Healthcare business, believes a nonprescription statin is probably inevitable in the U.S., and his firm still wants to be in early on that opportunity
You may also be interested in...
First EU Centralized Switch Goes To Alli, Could Spark More Applications
Central process will doubtless attract other switches, but countries will determine whether drug is still sold from pharmacies.
First EU Centralized Switch Goes To Alli, Could Spark More Applications
Central process will doubtless attract other switches, but countries will determine whether drug is still sold from pharmacies.
GSK Alli Strategy Relies Even More On Users Spreading The Word
Heading into its second year selling weight-loss drug alli over the counter, GlaxoSmithKline wants users to do the talking